Structure Therapeutics is trading 4.94% down now at $52.00 after closing at $54.70 on August 13, 2026, with no clear company-specific catalyst identified.
- Search results found no announcement, earnings release, or late-breaking filing dated August 13 explaining the after-hours decline.
- The latest major update was August 6 on second-quarter results and Phase 3 ACCOMPLISH initiation, making it stale context rather than a confirmed catalyst.
- Regular-session shares rose 1.47%; the seven-day trend was mixed, while volume and after-hours activity levels were unavailable.